Robert Hazlett, III, has joined SunTrust Robinson Humphrey Capital Markets as a director and senior research analyst covering pharmaceutical and specialty pharmaceutical companies.
Hazlett has six years experience covering the sector with UBS Securities, Lehman Brothers, and most recently with Robertson Stephens. His research has been recognized by the annual Institutional Investor and Reuters analyst polls.
With the addition of Hazlett, SunTrust Robinson Humphrey says it now has five healthcare analysts covering the full spectrum of biotech, facilities, information technology and diagnostic services, medical technology and pharmaceuticals sectors. SunTrust Robinson Humphrey’s Equity Research Department provides investment analysis on approximately 340 companies and their related industries.
SunTrust Robinson Humphrey Capital Markets provides equity research, investment banking, institutional sales and trading, and debt capital solutions to growing companies. By combining complementary strengths in products and services with in-depth industry knowledge, SunTrust Robinson Humphrey provides clients with innovative financial strategies and solutions.
Based in Atlanta, SunTrust Robinson Humphrey maintains a network of offices in Boston, Miami, Nashville, New York, Orlando, Pittsburgh, Richmond and Tampa. It is associated with Sun Trust Bank, which is also headquartered in Atlanta.
Sun Trust RH: www.suntrustrh.com
